Current management and future perspectives of penile cancer: an updated review
Penile cancer (PeCa) represents a rare disease worldwide, accounting for less than one percent of all malignancies in men [1] with devastating physical and psychological effects. Although PeCa may affect young males, it is most commonly diagnosed in the sixth and seventh decade of life [2]. While PeCa is uncommon in developed countries, it remains a significant public health concern in developing nations with an alarming higher incidence in some areas [3,4].
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Florent Peyraud, Cl ément Allenet, Marine Gross-Goupil, Charlotte Domblides, Félix Lefort, Amaury Daste, Mokrane Yacoub, Thibaud Haaser, Ludovic Ferretti, Grégoire Robert, Alain Ravaud Source Type: research
More News: Cancer | Cancer & Oncology | International Medicine & Public Health | Men | Penile Cancer | Psychology | Rare Diseases